[go: up one dir, main page]

AU2003265432A1 - Polyionic organic acid formulations - Google Patents

Polyionic organic acid formulations

Info

Publication number
AU2003265432A1
AU2003265432A1 AU2003265432A AU2003265432A AU2003265432A1 AU 2003265432 A1 AU2003265432 A1 AU 2003265432A1 AU 2003265432 A AU2003265432 A AU 2003265432A AU 2003265432 A AU2003265432 A AU 2003265432A AU 2003265432 A1 AU2003265432 A1 AU 2003265432A1
Authority
AU
Australia
Prior art keywords
organic acid
acid formulations
polyionic organic
polyionic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265432A
Other languages
English (en)
Other versions
AU2003265432A8 (en
Inventor
Michael J. Bennett
Yen-Ju Chen
Edmund J. Niedzinski
Hsien Tseng
Sean Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genteric Inc
Original Assignee
Genteric Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genteric Inc filed Critical Genteric Inc
Publication of AU2003265432A1 publication Critical patent/AU2003265432A1/en
Publication of AU2003265432A8 publication Critical patent/AU2003265432A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003265432A 2002-08-12 2003-08-12 Polyionic organic acid formulations Abandoned AU2003265432A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40281102P 2002-08-12 2002-08-12
US60/402,811 2002-08-12
US45399903P 2003-03-11 2003-03-11
US60/453,999 2003-03-11
US47614503P 2003-06-04 2003-06-04
US60/476,145 2003-06-04
PCT/US2003/025419 WO2004015089A2 (fr) 2002-08-12 2003-08-12 Formulations d'acide organique polyionique

Publications (2)

Publication Number Publication Date
AU2003265432A1 true AU2003265432A1 (en) 2004-02-25
AU2003265432A8 AU2003265432A8 (en) 2004-02-25

Family

ID=31721505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265432A Abandoned AU2003265432A1 (en) 2002-08-12 2003-08-12 Polyionic organic acid formulations

Country Status (2)

Country Link
AU (1) AU2003265432A1 (fr)
WO (1) WO2004015089A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888107B2 (en) 2006-07-24 2011-02-15 Nanosphere, Inc. System using self-contained processing module for detecting nucleic acids
US7625746B2 (en) 2006-07-24 2009-12-01 Nanosphere, Inc. Method of denaturing and fragmenting DNA or RNA using ultrasound
CZ301561B6 (cs) * 2007-12-04 2010-04-14 Výzkumný ústav živocišné výroby, v. v. i. Prostredek pro prevenci a potlacování kokcidióz
CA3040687A1 (fr) 2016-10-14 2018-04-19 Childrens' Medical Center Corporation Compositions et procedes pour le traitement de maladies ou de troubles du systeme nerveux central
CN110913872B (zh) * 2017-01-17 2023-08-04 儿童医疗中心有限公司 治疗溶酶体贮积疾病及病症的组合物和方法
US12000843B2 (en) 2017-01-17 2024-06-04 Children's Medical Center Corporation Compositions and methods for diagnosing and treating peroxisomal diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885971A (en) * 1995-03-24 1999-03-23 The Regents Of The University Of California Gene therapy by secretory gland expression
US5932539A (en) * 1996-10-15 1999-08-03 The Board Of Trustees Of The University Of Illinois Biodegradable polymer matrix for tissue repair
US6372722B1 (en) * 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells
US20020108132A1 (en) * 2001-02-02 2002-08-08 Avigenics Inc. Production of a monoclonal antibody by a transgenic chicken

Also Published As

Publication number Publication date
WO2004015089A2 (fr) 2004-02-19
AU2003265432A8 (en) 2004-02-25
WO2004015089A3 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2003296419A1 (en) Pyrenyloxysulfonic acid fluorescent agents
AU2003301516A1 (en) Antifungal formulations
AU2003224597A1 (en) Organic compositions
AU2003300056A1 (en) Organic compositions
AU2003266161A1 (en) High concentration topical insecticide
AU2003226487A1 (en) Formulation
AU2003267210A1 (en) Topical insecticide
AU2003289910A1 (en) Isophtalic acid derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2003287249A1 (en) Organic acid containing compositions and methods for use thereof
AU2002951396A0 (en) Horseshoe
AU2003217110A1 (en) Novel formulation
AU2003249294A1 (en) Fullerene compounds
AU2003265432A1 (en) Polyionic organic acid formulations
AUPS019802A0 (en) Nutrient formulation
AU2003219117A1 (en) Extended release venlafaxine formulations
AUPS015802A0 (en) Fumigant formulation
AU2002327300A1 (en) Remover solution
AUPS121202A0 (en) Platform
AU2003202905A1 (en) Organic composition
AU2003207330A1 (en) Reel-transporting platform
AU2002362143A1 (en) Process for puriying an organic acid
AU2003235429A1 (en) (2s)-2-ethylphenylpropionic acid derivative
AU2002236267A1 (en) Quinolonecarboxylic acid derivative

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase